HUTCHMED’s Post

Here at Centrient, we're committed to being a sustainable leader in the generics pharmaceuticals space. That's because thinking and acting sustainably is a key pillar of our purpose to improve lives through innovative and sustainable manufacturing of medicines. We channel this approach through our ESG Ambition 2021-2030. Our recently published Environmental, Social and Governance (ESG) Report provides an update on the steps we're taking to realise this ambition and support the health and wellbeing of people and the environment. The report is packed full of information, but here are some of the key highlights from our ESG activities over the past two years: • Environmental: 5% reduction in GHG emissions and new targets submitted to SBTi • Environmental: 97% of waste repurposed and 10% reduction in water consumption • Social: facilitated 1.5 billion patient treatments globally in 2023 • Social: progress on DEI, including 30% of senior management roles held by women • Governance: maintaining our EcoVadis Gold rating • Governance: completing a company-wide human rights impact assessment All this and more in the report here: https://lnkd.in/gvXGRYFg

Pharma companies tone down ESG mentions, but not ambitions https://lnkd.in/gNgDX54k Pharma companies are scaling back the use of terms like “ESG” and “diversity, equity and inclusion,” much like companies in other industries. In pharma 10-K filings, mentions of ESG, sustainability, or diversity, equity and inclusion [...]

Guiding 300 pharmacies towards sustainable management based on their carbon report - What action plans? 🌱 Join us to discover the challenges and key steps towards a more sustainable operation for the cooperatives Multipharma and Vpharma. A webinar organised in collaboration with Quentin Van Buylaere (Multipharma), Grégory Van Roy (VPharma), and Alexandre Philippe (IMPACT VALLEY) to address these questions: 📊 What obstacles must be overcome in terms of sustainability, and what are the cooperatives' expectations regarding a carbon report? ✅ What initiatives should be implemented to get everyone on board with this approach? 🔄 What methodology should be used to support businesses and foster a culture of sustainability after the carbon report? Don't miss the opportunity to interact directly with our speakers during this session. Register now! 👉 https://lnkd.in/eNSr3Ba4 Practical information: 📆 Tuesday, July 9th 🕦 11:30 AM - 12:15 PM (20 minutes of presentation and 15 minutes of Q&A) 🗣 Webinar conducted in French

When we recently talked with 800 biopharma professionals across 18 countries to explore the state of sustainability in biopharma, we found out that sustainability is a top business priority to 62% of these over the coming five years. Find out why in our 2024 Global Biopharma Sustainability Review. https://lnkd.in/dyzFBEzy

Tired of endlessly scrolling for new content…. Look no further 😉 We want to shed some light on the first key finding from our inaugural LogiPharma Sustainability Report 💡 📉 Our research has revealed just how pivotal the UN's Sustainability Development Goals (SDGs) will play in shaping the future of pharmaceutical supply chains. According to the report, an overwhelming 85% of respondents acknowledge that their current supply chain is only 'somewhat sustainable.' 🚀 The urgency of the UN SDGs as a call to action for environmental change is undeniable. As we navigate the path toward a more sustainable future, these goals are emerging as an essential blueprint for pharmaceutical leaders. 🤝 In the face of increasing pressure to reduce environmental footprints, the adoption of UN SDGs as a benchmark is a game-changer. It not only strengthens commitment but also ensures that supply chain leaders align their goals and promises with a globally recognized framework. Let's leverage this momentum to drive meaningful change in the pharmaceutical industry. Together, we can make a lasting impact on our planet while meeting the demands of an evolving landscape. 💚🌐 Be part of the journey…. Download your FREE copy here 👇 #Insights #SupplyChain #SupplyChainInsights 

The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives. #ESG #climatechange #sustainability

We just released our 2023 Amgen ESG Report. Environmental Sustainability (Healthy Planet section) highlights are: 1. We remain on track to meet our 2027 Ambition to dramatically reduce carbon, water, and waste footprints. 2. We advanced Amgen EcovationTM — our approach to innovative and sustainable manufacturing — with our newest biomanufacturing facility in Ohio that was built to LEED Gold standard and includes solar arrays. 3. We formalized our expectations of engagement with suppliers to support their adoption of science-based targets. This is important as more than an estimated 90% of our greenhouse gas emissions come from our value chain. #mycompany #sustainability #innovation https://lnkd.in/g89fRurs

#News: A survey of more than 800 #biopharma executives shows that #sustainability has become an increasingly important priority but that companies are struggling to achieve it and as a result are putting their business at risk. The study—which was conducted by the Danaher Corporation Corporation’s research and manufacturing subsidiary Cytiva and by Financial Times research unit FT Longitude —tabulated the input of execs from firms in 18 different countries. Of the respondents, 26% hold C-suite roles and 30% represent companies that generate more than $1 billion in annual revenue. “We want to drive a conversation around innovation and strategy on sustainability,” Emmanuel Abate , #Cytiva’s sustainability and corporate responsibility chief, said in a release. “These findings highlight where we as an industry must collaborate and push for better progress and prove the benefits of delivering on sustainability targets to employees, customers, and investors.” Read more from Fierce Pharma 👇🏽 https://lnkd.in/eZmEfrKg

Dear LinkedIn Community, I'm thrilled to announce that the recording of our recent webinar on "ESG Challenges in Pharma: Charting a Sustainable Course" is now live! 🌿 Key Takeaways: ✅ Exploring Sustainable Practices in Pharma ✅ Addressing Social Responsibility in Healthcare ✅ Navigating Governance Challenges ✅ Insights into Ethical Decision-Making in Pharma Whether you're part of the pharmaceutical industry, healthcare sector, or simply interested in corporate sustainability, this webinar is a must-watch. Gain valuable insights from industry experts and contribute to the ongoing conversation around creating a more sustainable and responsible future for Pharma. 👉 Join the discussion by watching the recording and sharing your thoughts in the comments. Your perspective is crucial in shaping the dialogue on ESG challenges in Pharma. Let's continue driving positive change together! 🌐✨ #ESG #pharmaceuticalindustry #sustainabilityreporting #webinarrecording #healthcare #corporateresponsibility #ESGChallenges

Read the inspiring collaboration story between AstraZeneca and its supplier MINAKEM who are both partnering with EcoVadis to advance sustainable practices including sustainable procurement, climate action, and diversity, equity, and inclusion (DEI), showcasing ongoing progress and commitment to sustainability goals. Find the case study below. https://ecovad.is/49h6Nfv #EcoVadisSuccessStory #Collaboration #DEI #SustainablePractices